No Data
TherapeuticsMD Inc. Stock Advances 11.4%, Outperforms Market
TherapeuticsMD Inc. Stock Slides 4.8%, Underperforms Market
TherapeuticsMD Inc. Stock Rallies 4.1%, Outperforms Market
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Mayne Pharma Faces Legal Challenge From TherapeuticsMD
TherapeuticsMD Full Year 2024 Earnings: US$0.20 Loss per Share (Vs US$0.74 Loss in FY 2023)
